Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090–3.CrossrefPubMedGoogle Scholar
Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009;94:1748–52.PubMedCrossrefWeb of ScienceGoogle Scholar
Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW. Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol 2012;87: 977–83.PubMedWeb of ScienceCrossrefGoogle Scholar
van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, et al. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem 2016;62:993–1001.CrossrefPubMedWeb of ScienceGoogle Scholar
Vesper HW, Myers GL, Miller WG. Current practices and challenges in the standardization and harmonization of clinical laboratory tests. Am J Clin Nutr 2016;104:907S–12S.Google Scholar
ISO17511:2003. In vitro diagnostic medical devices – measurement of quantities in biological samples – metrological traceability of values assigned to calibrators and control materials. https://www.iso.org/standard/30716.html. Accessed: 10 Sept 2018.
Myers GL, Miller WG. The roadmap for harmonization: status of the international consortium for harmonization of clinical laboratory results. Clin Chem Lab Med 2018;56:1667–72.Web of SciencePubMedCrossrefGoogle Scholar
Weykamp C, Eckfeld J, Vesper H, Thienpont L, Burns C, Caliendo A, et al. AACC harmonization initiative; toolbox of technical procedures to achieve harmonization for a measurand 2012. www.harmonization.net. Accessed: 10 Sept 2018.
Bros P, Josephs RD, Stoppacher N, Cazals G, Lehmann S, Hirtz C, et al. Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators. Anal Bioanal Chem 2017;409:2559–67.Web of SciencePubMedCrossrefGoogle Scholar
Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, et al. Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS One 2013;8:e75518.CrossrefPubMedWeb of ScienceGoogle Scholar
Pechlaner R, Kiechl S, Mayr M, Santer P, Weger S, Haschka D, et al. Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clin Chem Lab Med 2016;54:151–61.Web of ScienceGoogle Scholar
Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007;21:4033–8.CrossrefPubMedWeb of ScienceGoogle Scholar
Udali S, Castagna A, Corbella M, Ruzzenente A, Moruzzi S, Mazzi F, et al. Hepcidin and DNA promoter methylation in hepatocellular carcinoma. Eur J Clin Invest 2018;48.Web of SciencePubMedGoogle Scholar
Itkonen O, Parkkinen J, Stenman UH, Hamalainen E. Preanalytical factors and reference intervals for serum hepcidin lc-ms/ms method. Clin Chim Acta 2012;413:696–701.Web of SciencePubMedCrossrefGoogle Scholar
Lefebvre T, Dessendier N, Houamel D, Ialy-Radio N, Kannengiesser C, Manceau H, et al. Lc-ms/ms method for hepcidin-25 measurement in human and mouse serum: Clinical and research implications in iron disorders. Clin Chem Lab Med 2015;53:1557–67.Web of SciencePubMedGoogle Scholar
Abbas IM, Hoffmann H, Montes-Bayon M, Weller MG. Improved lc-ms/ms method for the quantification of hepcidin-25 in clinical samples. Anal Bioanal Chem 2018;410:3835–46.PubMedWeb of ScienceCrossrefGoogle Scholar
Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010;56:1570–9.CrossrefPubMedWeb of ScienceGoogle Scholar
Zipperer E, Post JG, Herkert M, Kundgen A, Fox F, Haas R, et al. Serum hepcidin measured with an improved elisa correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Ann Hematol 2013;92:1617–23.Web of SciencePubMedCrossrefGoogle Scholar
Butterfield AM, Luan P, Witcher DR, Manetta J, Murphy AT, Wroblewski VJ, et al. A dual-monoclonal sandwich elisa specific for hepcidin-25. Clin Chem 2010;56:1725–32.CrossrefPubMedWeb of ScienceGoogle Scholar
Budd JR, Weykamp C, Rej R, MacKenzie F, Ceriotti F, Greenberg N, et al. IFCC working group recommendations for assessing commutability part 3: using the calibration effectiveness of a reference material. Clin Chem 2018;64:465–74.CrossrefWeb of ScienceGoogle Scholar
Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007;110:1048–54.PubMedWeb of ScienceCrossrefGoogle Scholar
ISO13528:2005. Statistical methods for use in proficiency testing by interlaboratory comparisons. https://www.iso.org/standard/35664.html. Accessed: 10 Sept 2018.
ISO/IECGuide98-3:2008. Uncertainty of measurement – part 3: guide to the expression of uncertainty in measurement (gum:1995). https://www.iso.org/standard/50461.html. Accessed: 10 Sept 2018.
Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 2009; 389:124–9.CrossrefPubMedWeb of ScienceGoogle Scholar
Schaap CC, Hendriks JC, Kortman GA, Klaver SM, Kroot JJ, Laarakkers CM, et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem 2013; 59:527–35.PubMedCrossrefWeb of ScienceGoogle Scholar
About the article
Published Online: 2018-11-29
Published in Print: 2019-05-27
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: We would like to acknowledge Fondazione Cariverona. The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Employment or leadership: LD, CL, SK, RvS and DS are employees of Radboudumc, that via its Hepcidinanalysis.com initiative offers high quality hepcidin measurements to the medical, scientific and pharmaceutical community at a fee for the service basis. KRP is an employee of Corgenix Medical Corporation specializing in IVD development, manufacturing, and distribution. MW (deceased) was President and CEO of Intrinsic LifeSciences LLC. GO is an employee of Intrinsic LifeSciences LLC and has ownership interest in the company. Intrinsic LifeSciences is engaged in the commercial development of hepcidin and related diagnostic products and provides CLIA compliant hepcidin testing to research, clinical and pharmaceutical clients worldwide.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.